Exchange Traded Concepts, LLC Incyte Corp Transaction History

Exchange Traded Concepts, LLC

$4.18 Billion
Q3 2024

A detailed history of Exchange Traded Concepts, LLC transactions in Incyte Corp stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 33,325 shares of INCY stock, worth $2.39 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

33,325

Previous 18,372 81.39%

Holding current value

$2.39 Million

Previous $1.11 Million 97.84%

% of portfolio

0.05%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$57.33 - $68.61 $857,255 - $1.03 Million	14,953 Added 81.39%	33,325 $2.2 Million
Q2 2024 Aug 13, 2024	SELL	$51.18 - $63.75 $13,153 - $16,383	-257 Reduced 1.38%	18,372 $1.11 Million
Q1 2024 Apr 15, 2024	SELL	$56.55 - $66.59 $609,495 - $717,707	-10,778 Reduced 36.65%	18,629 $1.06 Million
Q4 2023 Jan 05, 2024	SELL	$52.16 - $64.19 $25,714 - $31,645	-493 Reduced 1.65%	29,407 $1.85 Million
Q3 2023 Oct 18, 2023	SELL	$57.77 - $65.93 $326,169 - $372,240	-5,646 Reduced 15.88%	29,900 $1.73 Million
Q2 2023 Jul 20, 2023	SELL	$60.95 - $75.51 $2.11 Million - $2.61 Million	-34,569 Reduced 49.3%	35,546 $2.21 Million
Q1 2023 Apr 12, 2023	BUY	$70.23 - $86.01 $3.15 Million - $3.86 Million	44,824 Added 177.23%	70,115 $5.07 Million
Q4 2022 Jan 17, 2023	SELL	$67.18 - $84.11 $136,980 - $171,500	-2,039 Reduced 7.46%	25,291 $2.03 Million
Q3 2022 Oct 07, 2022	BUY	$66.18 - $82.86 $155,390 - $194,555	2,348 Added 9.4%	27,330 $1.82 Million
Q2 2022 Jul 20, 2022	SELL	$66.18 - $83.18 $501,313 - $630,088	-7,575 Reduced 23.27%	24,982 $1.9 Million
Q1 2022 Apr 26, 2022	SELL	$66.02 - $79.71 $3.46 Million - $4.18 Million	-52,382 Reduced 61.67%	32,557 $2.59 Million
Q4 2021 Jan 13, 2022	BUY	$63.34 - $74.11 $2.48 Million - $2.9 Million	39,140 Added 85.46%	84,939 $6.24 Million
Q3 2021 Oct 18, 2021	BUY	$68.67 - $84.02 $167,760 - $205,260	2,443 Added 5.63%	45,799 $3.15 Million
Q2 2021 Jul 30, 2021	BUY	$79.87 - $87.53 $167,167 - $183,200	2,093 Added 5.07%	43,356 $3.65 Million
Q1 2021 Apr 20, 2021	BUY	$76.02 - $100.5 $707,518 - $935,353	9,307 Added 29.12%	41,263 $3.35 Million
Q4 2020 Jan 19, 2021	BUY	$80.74 - $97.7 $1.14 Million - $1.37 Million	14,071 Added 78.67%	31,956 $2.78 Million
Q3 2020 Oct 30, 2020	BUY	$85.07 - $109.69 $922,669 - $1.19 Million	10,846 Added 154.08%	17,885 $1.61 Million
Q2 2020 Jul 15, 2020	BUY	$74.18 - $108.93 $370,009 - $543,342	4,988 Added 243.2%	7,039 $732,000
Q1 2020 Apr 14, 2020	BUY	$63.18 - $85.97 $33,169 - $45,134	525 Added 34.4%	2,051 $150,000
Q4 2019 Jan 22, 2020	BUY	$73.04 - $95.72 $111,459 - $146,068	1,526 New	1,526 $133,000

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Account

Exchange Traded Concepts, LLC Incyte Corp Transaction History